Borchert RJ, Azevedo T, Badhwar A, et al. Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review. Alzheimer’s & dementia : the journal of the Alzheimer’s Association. 2023. doi:10.1002/alz.13412
Publications
Tsaktanis T, Linnerbauer M, Lößlein L, et al. Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis. Brain communications. 2023;5(4):fcad206. doi:10.1093/braincomms/fcad206
Schlam I, Moges R, Morganti S, Tolaney SM, Tarantino P. Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2. Critical reviews in oncology/hematology. 2023:104090. doi:10.1016/j.critrevonc.2023.104090
Ben-Mahmoud A, Kishikawa S, Gupta V, et al. A cryptic microdeletion del(12)(p11.21p11.23) within an unbalanced translocation t(7;12)(q21.13;q23.1) implicates new candidate loci for intellectual disability and Kallmann syndrome. Scientific reports. 2023;13(1):12984. doi:10.1038/s41598-023-40037-4
Lu AT, Fei Z, Haghani A, et al. Universal DNA methylation age across mammalian tissues. Nature aging. 2023. doi:10.1038/s43587-023-00462-6
Detappe A, Nguyen HVT, Jiang Y, et al. Author Correction: Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma. Nature nanotechnology. 2023. doi:10.1038/s41565-023-01499-9
Mayo KR, Basford MA, Carroll RJ, et al. The Data and Research Center: Creating a Secure, Scalable, and Sustainable Ecosystem for Biomedical Research. Annual review of biomedical data science. 2023;6:443-464. doi:10.1146/annurev-biodatasci-122120-104825
Kudtarkar P, Costanzo MC, Sun Y, et al. Leveraging type 1 diabetes human genetic and genomic data in the T1D knowledge portal. PLoS biology. 2023;21(8):e3002233. doi:10.1371/journal.pbio.3002233
Haghani A, Li CZ, Robeck TR, et al. DNA methylation networks underlying mammalian traits. Science (New York, N.Y.). 2023;381(6658):eabq5693. doi:10.1126/science.abq5693
Wojcik MH, Reuter CM, Marwaha S, et al. Beyond the exome: what’s next in diagnostic testing for Mendelian conditions. ArXiv. 2023.